Back to Search Start Over

Plasmodium vivaxmalaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi

Authors :
Longley, Rhea J.
Grigg, Matthew J.
Schoffer, Kael
Obadia, Thomas
Hyslop, Stephanie
Piera, Kim A.
Nekkab, Narimane
Mazhari, Ramin
Takashima, Eizo
Tsuboi, Takafumi
Harbers, Matthias
Tetteh, Kevin
Drakeley, Chris
Chitnis, Chetan E.
Healer, Julie
Tham, Wai-Hong
Sattabongkot, Jetsumon
White, Michael T.
Cooper, Daniel J.
Rajahram, Giri S.
Barber, Bridget E.
William, Timothy
Anstey, Nicholas M.
Mueller, Ivo
Source :
Cell Reports Medicine; June 2022, Vol. 3 Issue: 6
Publication Year :
2022

Abstract

Serological markers are a promising tool for surveillance and targeted interventions for Plasmodium vivaxmalaria. P. vivaxis closely related to the zoonotic parasite P. knowlesi, which also infects humans. P. vivaxand P. knowlesiare co-endemic across much of South East Asia, making it important to design serological markers that minimize cross-reactivity in this region. To determine the degree of IgG cross-reactivity against a panel of P. vivaxserological markers, we assayed samples from human patients with P. knowlesimalaria. IgG antibody reactivity is high against P. vivaxproteins with high sequence identity with their P. knowlesiortholog. IgG reactivity peaks at 7 days post-P. knowlesiinfection and is short-lived, with minimal responses 1 year post-infection. We designed a panel of eight P. vivaxproteins with low levels of cross-reactivity with P. knowlesi. This panel can accurately classify recent P. vivaxinfections while reducing misclassification of recent P. knowlesiinfections.

Details

Language :
English
ISSN :
26663791
Volume :
3
Issue :
6
Database :
Supplemental Index
Journal :
Cell Reports Medicine
Publication Type :
Periodical
Accession number :
ejs60234568
Full Text :
https://doi.org/10.1016/j.xcrm.2022.100662